Astera Labs (NASDAQ:ALAB) Issues Q3 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) updated its third quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.160-1.210 for the period, compared to the consensus EPS estimate of 0.730. The company issued revenue guidance of $540.0 million-$560.0 million, compared to the consensus revenue estimate of $410.3 million.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded up $40.62 during midday trading on Tuesday, hitting $361.67. 10,002,005 shares of the stock traded hands, compared to its average volume of 5,563,163. The firm has a market capitalization of $61.99 billion, a P/E ratio of 244.37, a PEG ratio of 3.61 and a beta of 3.84. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The firm has a 50-day moving average of $360.26 and a two-hundred day moving average of $231.18.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the firm posted $0.44 earnings per share. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs will post 1.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ALAB shares. Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Evercore reaffirmed an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Stifel Nicolaus lifted their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. UBS Group boosted their price target on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $335.00 price objective on shares of Astera Labs in a research note on Monday. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $289.00.

Insider Transactions at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $1,577,250.00. Following the sale, the director directly owned 57,466 shares in the company, valued at approximately $25,859,700. The trade was a 5.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director owned 286,863 shares of the company’s stock, valued at $131,492,261.94. This represents a 2.87% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,676,845 shares of company stock valued at $444,928,806. 10.40% of the stock is owned by insiders.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Strong Q2 earnings beat: Astera Labs reported adjusted EPS of $0.80, exceeding the $0.69 consensus estimate, while revenue reached $392.4 million versus expectations of $360.85 million. The company also posted a 26.72% net margin and 18.49% return on equity. Astera Labs quarterly earnings press release
• Positive Sentiment: Record revenue growth: Second-quarter revenue increased 27% sequentially and 104% year over year, with growth described as diversified across AI fabrics and signal-conditioning products. Astera Labs Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Raised outlook far above estimates: Astera Labs guided for third-quarter EPS of $1.16–$1.21, compared with the $0.73 consensus, and revenue of $540 million–$560 million versus the $410.3 million consensus. The outlook suggests accelerating demand and improving operating leverage.
• Positive Sentiment: New product ramp: Management expects the Scorpio X-Series 320-lane fabric switch production ramp to drive a third-quarter revenue inflection, supporting investor expectations for continued AI-related growth. Astera Labs Stock Shoots Higher After Q2 Earnings
• Neutral Sentiment: Pre-earnings commentary highlighted benefits from Astera Labs’ partnership with Amazon and continued investor interest in AI infrastructure suppliers. Analysts also raised a price target to $275, although that target is below the stock’s current trading level, indicating valuation concerns despite the strong results.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Great Valley Advisor Group Inc. increased its stake in shares of Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after acquiring an additional 90 shares during the last quarter. National Bank of Canada FI lifted its holdings in shares of Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after acquiring an additional 124 shares during the period. Smartleaf Asset Management LLC boosted its position in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the last quarter. Prosperity Wealth Management Inc. boosted its position in shares of Astera Labs by 4.1% in the third quarter. Prosperity Wealth Management Inc. now owns 4,300 shares of the company’s stock worth $842,000 after acquiring an additional 168 shares during the last quarter. Finally, State of Wyoming boosted its position in shares of Astera Labs by 29.1% in the fourth quarter. State of Wyoming now owns 826 shares of the company’s stock worth $137,000 after acquiring an additional 186 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.